Professional-grade financial intelligence

20M+ securities. Real-time data. Institutional insights.

Subscribe for $2

Trusted by professionals at Goldman Sachs, BlackRock, and JPMorgan

Overview
Profile
Pediatrix Medical Group Stock

Pediatrix Medical Group Stock MD

MD
US58502B1061
A0RELL

Price

0
Today +/-
-0
Today %
-0 %

Pediatrix Medical Group stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Pediatrix Medical Group stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Pediatrix Medical Group stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Pediatrix Medical Group stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Pediatrix Medical Group's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Pediatrix Medical Group Stock Price History

DatePediatrix Medical Group Price
7/29/20250 undefined
7/25/202512.62 undefined
7/24/202512.54 undefined
7/23/202513.04 undefined
7/22/202512.76 undefined
7/21/202512.78 undefined
7/18/202512.57 undefined
7/17/202512.83 undefined
7/16/202512.84 undefined
7/15/202512.91 undefined
7/14/202513.18 undefined
7/11/202513.14 undefined
7/10/202513.52 undefined
7/9/202513.58 undefined
7/8/202513.56 undefined
7/7/202513.47 undefined
7/3/202513.80 undefined
7/2/202513.80 undefined
7/1/202514.32 undefined
6/30/202514.37 undefined

Pediatrix Medical Group Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Pediatrix Medical Group, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Pediatrix Medical Group from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Pediatrix Medical Group’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Pediatrix Medical Group. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Pediatrix Medical Group’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Pediatrix Medical Group’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Pediatrix Medical Group’s growth potential.

Pediatrix Medical Group Revenue, EBIT and net profit per share

DatePediatrix Medical Group RevenuePediatrix Medical Group EBITPediatrix Medical Group Net Income
2029e2.3 B undefined0 undefined133.04 M undefined
2028e2.19 B undefined0 undefined136.47 M undefined
2027e2.09 B undefined227.15 M undefined151.21 M undefined
2026e1.99 B undefined218.4 M undefined147.42 M undefined
2025e1.93 B undefined209.08 M undefined142.9 M undefined
20242.01 B undefined183.68 M undefined-99.07 M undefined
20231.99 B undefined157.85 M undefined-60.41 M undefined
20221.97 B undefined200 M undefined66.34 M undefined
20211.91 B undefined217.74 M undefined130.96 M undefined
20201.73 B undefined171.9 M undefined-796.5 M undefined
20191.78 B undefined232.7 M undefined-1.5 B undefined
20181.72 B undefined248.4 M undefined268.6 M undefined
20173.25 B undefined454.9 M undefined320.4 M undefined
20163.18 B undefined571.7 M undefined324.9 M undefined
20152.78 B undefined557.9 M undefined336.3 M undefined
20142.44 B undefined513 M undefined317.3 M undefined
20132.15 B undefined452.1 M undefined280.5 M undefined
20121.82 B undefined389.5 M undefined240.9 M undefined
20111.59 B undefined355.4 M undefined218 M undefined
20101.4 B undefined312.9 M undefined202.7 M undefined
20091.29 B undefined288.9 M undefined175.8 M undefined
20081.07 B undefined242 M undefined169.2 M undefined
2007917.6 M undefined220.9 M undefined142.7 M undefined
2006804.7 M undefined194.4 M undefined124.5 M undefined
2005680.8 M undefined142.9 M undefined87.5 M undefined

Pediatrix Medical Group Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M)
NET INCOME (M)
NET INCOME GROWTH (%)
SHARES (M)
DOCUMENTS
199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e2028e2029e
0.010.010.020.020.030.040.080.130.190.230.240.350.470.550.620.680.80.921.071.291.41.591.822.152.442.783.183.251.721.781.731.911.971.992.011.931.992.092.192.3
-66.6750.0053.3339.1334.3886.0560.0044.5322.707.0545.6831.3618.4912.349.8518.2414.0516.4720.608.7713.3514.3618.6113.1814.0314.502.20-47.033.25-2.5310.213.191.120.90-4.083.214.924.934.74
7,783.334,670.003,113.332,030.431,459.381,086.05583.75364.84252.43205.73192.18131.92100.4384.7575.4468.6858.0850.9343.7336.2633.3329.4125.7221.6819.1616.8014.6714.3627.1026.2526.9326.8423.6823.4223.2124.2023.4422.3421.3020.33
00000000000000000000000000000005134670000000
11-745613202925113068849687124142169175202218240280317336324320268-1,497-79613066-60-99142147151136133
---800.00-157.1425.0020.00116.6753.8545.00-13.79-56.00172.73126.6723.5314.29-9.3842.5314.5219.013.5515.437.9210.0916.6713.215.99-3.57-1.23-16.25-658.58-46.83-116.33-49.23-190.9165.00-243.433.522.72-9.93-2.21
45.545.545.545.543.847.458.16363.963.464.289.9106.598.399.596.198.899.894.392.995.197.699.410199.99493.19391.683.583.484.8384.1282.283.3300000
----------------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Pediatrix Medical Group Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Pediatrix Medical Group is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETS
CASH BALANCE (B)
RECEIVABLES (M)
OTHER REC. (M)
INVENTORIES (M)
OTHER CURRENT LIAB. (M)
CURRENT ASSETS (B)
TANGIBLE ASSETS (M)
LONG-T. INVEST. (M)
LONG-T. REC. (M)
INTANGIBLE ASSETS (M)
GOODWILL (B)
OTHER NON-CURRENT ASSETS (M)
NON-CURRENT ASSETS (B)
TOTAL ASSETS (B)
LIABILITIES
COMMON STOCK (M)
ADDITIONAL PAID-IN CAPITAL (B)
RETAINED EARNINGS (B)
OTHER EQUITY (M)
UNREAL. GAINS/LOSSES (k)
EQUITY (B)
LIABILITIES (M)
PROVISIONS (M)
OTHER SHORT-TERM LIAB. (M)
SHORT-TERM DEBTS (M)
LONG-TERM DEBT PORTION (M)
SHORT-TERM REC. (M)
LONG-T. LIAB. (B)
DEFERRED TAXES (M)
OTHER LIAB. (M)
LONG-T. LIABILITIES (B)
DEBT (B)
TOTAL CAPITAL (B)
19931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                                               
00.010.050.080.050000.030.070.030.020.020.140.120.040.030.040.020.030.040.050.060.070.070.050.191.230.490.10.180.35
7.7912.123.441.861.677.769.163.975.494.2107.9111.7125.6145.5162.4164.4181.4230.4248.1285.4352.2444.7495.3504506.7498.9241.9301.78296.79272.31259.99
0.60.10.30.20000000000005.70000000000014.2507.5712.61
00000000000000000000000000000000
0.20.61.11.71.51.51.51.621.512.823.527.430.840.897.887.490.67184.183.245.260.922.624.952.8105.845.378.737.4328.1425.8318.5
0.010.020.060.10.090.060.080.070.110.160.150.150.160.30.360.280.290.30.340.360.370.470.530.590.630.660.731.550.840.430.480.64
2.734.58.79.911.913.69.614.816.827.226.627.929.931.238.843.342.860.559.759.96683.6103.1123.590.4177.3132.2135.62140.21145.9378.44
0000000000004.16.717.516.228.527.44547.657.564.163.37980.769.7000000
000000000000000000000000000014.25000
001.71.71.71.71.71.71.717.88.98.27.211.413.938.851.865.398.50198.1424.2668.5639.9313.2274.426.621.5718.4921.2411.6
0000.050.10.190.240.230.440.460.530.590.680.770.861.131.271.61.752.172.392.783.373.854.284.062.711.481.511.531.381.24
0.60.10.10.612.33.85.77.66.59.712.215.519.519.715.115.918.417.819.8129.436.782.256.5111.9742.8252.4161.8219.37229.1185.02180.45
000.010.060.110.210.250.250.460.490.570.640.740.830.941.211.41.741.942.392.643.144.024.755.245.283.411.81.91.921.741.51
0.010.020.070.160.20.270.330.320.570.650.720.790.91.141.31.51.692.042.272.753.013.614.555.345.875.944.153.352.742.352.222.15
                                                               
14.515.80.10.10.20.20.20.20.30.30.20.20.50.50.50.50.50.50.50.5110.90.90.90.90.80.90.860.830.840.86
000.060.120.120.130.130.140.340.390.360.370.470.520.560.560.60.660.720.790.860.890.930.971.020.990.991.031.050.9811.01
-000.010.020.040.070.10.110.140.210.210.20.220.350.40.410.590.791.011.251.481.381.511.792.052.090.51-0.29-0.16-0.09-0.15-0.25
000000000000-15.6000000000000003.51.32-3.74-2.21-1.07
0000100000000000000000000000000000
0.010.020.060.140.160.20.230.240.480.60.570.570.680.870.960.971.191.451.732.042.342.262.442.763.073.091.50.750.90.890.850.76
2.32.80.82.59.910.49.79.712.610.110.513.45.65.95.610.611.29.612.313.818.632.82228.534.631.139.659.836.6531.8634.5946.43
003.610.913.219.719.420.260.666.3101.4115.6170200.6237.5292335.3198.4222.3241.8290.1347.9373.8379.5403.4417.5495.6382.3377.16363.96337.29364.96
0.50.51.96.111.718.518.618.44.84.98.41.41.214.321.314.301319.612.617.925.221.1199253.96.5011.0716.272.162.17
00000048.423.5000000000000000000000000
0.10.10.10.20.20.20.200.50.50.70.60.90.50.50.30.20.10.10.10.110.511.922.11.40.30.12.22.4914.914.9120.55
2.93.46.419.73548.896.371.878.581.8121131177.7221.3264.9317.2346.7221.1254.3268.3326.7416.4428.8449.1531.4502.8541.8444.3427.37426.98388.95434.11
000000.01000000.050000.140.050.150.030.140.030.561.261.681.851.971.731.7410.640.620.6
0000.22.43.35.17.29.813.317.424.129.634.340.546.959.574.193.8125.9111.4160.5189227.8147.895.65861.741.4133.6434.3134.25
0000012.33.93.13.65.68.110.413.437.927.942.9148.5164.2176.5200.4207.6228.8218.3270.2277316.8351.6354.82359.25329.07322.29
00000.010.010.010.010.020.020.020.090.040.050.080.210.150.370.290.450.340.931.682.132.272.352.112.161.41.030.980.95
000.010.020.040.060.110.080.090.10.150.220.220.270.340.530.50.590.540.710.671.342.112.582.82.852.652.61.831.461.371.39
0.010.020.070.160.20.260.330.320.570.70.720.790.91.141.31.51.692.042.272.753.013.614.555.345.875.944.153.352.722.352.222.15
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Pediatrix Medical Group provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Pediatrix Medical Group's financial health and stability.

Assets

Pediatrix Medical Group's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Pediatrix Medical Group must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Pediatrix Medical Group after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Pediatrix Medical Group's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)
DEPRECIATION (M)
DEFERRED TAXES (M)
CHANGES IN WORKING CAPITAL (M)
NON-CASH ITEM (B)
PAID INTEREST (M)
PAID TAXES (M)
NET CASH FLOW FROM OPERATING ACTIVITIES (M)
CAPITAL EXPENDITURES (M)
CASH FLOW FROM INVESTING ACTIVITIES (M)
CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)
INTEREST INCOME AND EXPENSES (M)
NET DEBT CHANGE (M)
NET CHANGE IN EQUITY (M)
CASH FLOW FROM FINANCING ACTIVITIES (M)
CASH FLOW FROM OTHER FINANCING ACTIVITIES ()
TOTAL DIVIDENDS PAID (M)
NET CHANGE IN CASH FLOW (B)
FREE CASH FLOW (M)
SHARE-BASED COMPENSATION (M)
19921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
-745613202925113068849687124142169175202218240280317335324320268-1,497-79613066-60
0000148121321689991013162225304046648978242528323536
-21014655-1-141-951-1-7-137248211521418-61-35-5536-31-223
-200-2-4-2-9-1812532135105126263017-35-823427-76-27129-901652-2331-11
00000000000000.010.020.0300.050.050.060.060.070.060.060.070.060.181.90.92-0.010.070.18
0000001232111210332223720607382951108611642
0022321014823204640355379104113881191291261611811767518586-27542630
-134551429332436909711812316217718818124124027032440542236844349731335720476166137
0-10-1-4-2-3-3-4-7-8-15-7-7-12-8-15-14-12-31-14-15-18-27-39-26-17-19-28-32-29-33
0-10-34-76-32-65-72-8-30-33-90-80-104-155-90-222-163-361-190-460-263-503-848-821-576-142102815-53-56-48
000-32-72-30-61-68-3-23-25-75-73-97-143-82-207-148-349-159-446-247-485-820-782-550-125121844-20-27-14
00000000000000000000000000000000
100020740-27-500052-5400137-8996-119112-117536713427145129-239-1-762-405-19
12-203959358115-17-72-116138-64-18423253835-4-428-203-35-46-285-134-12-833
13-20396131348-25-35-18-72-63-5337-64-47-66120-87138-1329748238189-170-393-4-760-487-25
-------------------1.00-6.00-9.00-10.00-10.00-27.00-10.00-8.00-13.00-19.00-1.00---10.00
00000000000000000000000000000000
0000.0100-0.02000.020.05-0.05-0.0200.060.03-0.090.010-0.0100.010.02000.0100.071.02-0.74-0.380.06
-13.72.84.8410.126.830.520.431.883.289.8102.7116.7154.5164.4180165.7226.5228.5239.4310.4389.7404.5341.6404.5471.3296.6338.4175.844.49137.23104
00000000000000000000000000000000

Pediatrix Medical Group stock margins

The Pediatrix Medical Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Pediatrix Medical Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Pediatrix Medical Group.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Pediatrix Medical Group's sales revenue. A higher gross margin percentage indicates that the Pediatrix Medical Group retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Pediatrix Medical Group's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Pediatrix Medical Group's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Pediatrix Medical Group's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Pediatrix Medical Group. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Pediatrix Medical Group's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Pediatrix Medical Group Margin History

Pediatrix Medical Group Gross marginPediatrix Medical Group Profit marginPediatrix Medical Group EBIT marginPediatrix Medical Group Profit margin
2029e23.68 %0 %5.79 %
2028e23.68 %0 %6.22 %
2027e23.68 %10.87 %7.23 %
2026e23.68 %10.96 %7.4 %
2025e23.68 %10.83 %7.4 %
202423.68 %9.13 %-4.92 %
202323.68 %7.91 %-3.03 %
202223.68 %10.14 %3.36 %
202126.85 %11.39 %6.85 %
202023.68 %9.91 %-45.93 %
201923.68 %13.07 %-84.15 %
201823.68 %14.42 %15.59 %
201723.68 %13.98 %9.85 %
201623.68 %17.96 %10.21 %
201523.68 %20.07 %12.1 %
201423.68 %21.03 %13.01 %
201323.68 %20.99 %13.02 %
201223.68 %21.44 %13.26 %
201123.68 %22.38 %13.73 %
201023.68 %22.32 %14.46 %
200923.68 %22.42 %13.65 %
200823.68 %22.65 %15.84 %
200723.68 %24.07 %15.55 %
200623.68 %24.16 %15.47 %
200523.68 %20.99 %12.85 %

Pediatrix Medical Group Stock Sales Revenue, EBIT, Earnings per Share

The Pediatrix Medical Group earnings per share therefore indicates how much revenue Pediatrix Medical Group has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Pediatrix Medical Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Pediatrix Medical Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Pediatrix Medical Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Pediatrix Medical Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Pediatrix Medical Group Revenue, EBIT and net profit per share

DatePediatrix Medical Group Sales per SharePediatrix Medical Group EBIT per sharePediatrix Medical Group Earnings per Share
2029e27.58 undefined0 undefined1.6 undefined
2028e26.33 undefined0 undefined1.64 undefined
2027e25.08 undefined0 undefined1.81 undefined
2026e23.92 undefined0 undefined1.77 undefined
2025e23.16 undefined0 undefined1.71 undefined
202424.16 undefined2.2 undefined-1.19 undefined
202324.27 undefined1.92 undefined-0.73 undefined
202223.44 undefined2.38 undefined0.79 undefined
202122.53 undefined2.57 undefined1.54 undefined
202020.79 undefined2.06 undefined-9.55 undefined
201921.31 undefined2.79 undefined-17.94 undefined
201818.81 undefined2.71 undefined2.93 undefined
201734.98 undefined4.89 undefined3.45 undefined
201634.19 undefined6.14 undefined3.49 undefined
201529.57 undefined5.94 undefined3.58 undefined
201424.41 undefined5.14 undefined3.18 undefined
201321.33 undefined4.48 undefined2.78 undefined
201218.28 undefined3.92 undefined2.42 undefined
201116.27 undefined3.64 undefined2.23 undefined
201014.74 undefined3.29 undefined2.13 undefined
200913.87 undefined3.11 undefined1.89 undefined
200811.33 undefined2.57 undefined1.79 undefined
20079.19 undefined2.21 undefined1.43 undefined
20068.14 undefined1.97 undefined1.26 undefined
20057.08 undefined1.49 undefined0.91 undefined

Pediatrix Medical Group business model

MEDNAX Inc. is an American company that provides medical services for newborns, children, and adults. The company was founded in 1979 in Florida and is headquartered in Sunrise, Florida. It is listed on the New York Stock Exchange and has an annual revenue of approximately $3.5 billion. MEDNAX's business model is to offer specialized medical services for newborns, children, and adults in hospitals, emergency rooms, and medical practices in the United States. The company operates a vertically integrated management structure that covers all aspects of healthcare, from clinical management to billing and coding. MEDNAX specializes in a wide range of specialties such as anesthesia, pediatrics, neonatology, intensive care, cardiology, radiology, and pathology. The company's history began in 1979 in Florida with the founding of the American Anesthesiology Practice (AAP). AAP has become a leading anesthesia service provider in Florida, serving hospitals, surgeons, and patients. In 1995, MEDNAX established the Florida Neonatology Practice (FNP) to provide specialized treatments for premature and sick newborns. In 2008, the company officially changed its name to MEDNAX. MEDNAX expanded through acquisitions of companies and practices. In 2010, MEDNAX acquired Pediatrix Medical Group, a leading provider of medical services for newborns, pregnant women, and women with high-risk pregnancies. In 2013, the company acquired Sheridan Healthcare, a market leader in anesthesia, radiology, and emergency medicine. In 2017, the company launched a new division in cardiology and acquired CardioSolutions, a company specializing in cardiac procedures. MEDNAX offers a wide range of medical services, divided into different divisions. These include neonatology, pediatrics, anesthesia, radiology, and pathology. The company also offers various products and services tailored to the specific needs of patients and physicians in the United States, such as cardiac services, coding and billing services, anesthesia devices, and preterm birth screening tests. Overall, MEDNAX is a leading provider of medical services in the United States, with a diverse range of specialties and services, and a growing presence through acquisitions. Pediatrix Medical Group is one of the most popular companies on Eulerpool.com.

Pediatrix Medical Group SWOT Analysis

Strengths

MEDNAX Inc possesses several strengths that contribute to its success:

  • Extensive network of healthcare providers and specialists
  • Strong financial position
  • Excellent reputation and brand recognition
  • Advanced medical technology and infrastructure
  • Robust research and development capabilities

Weaknesses

Despite its strengths, MEDNAX Inc also faces certain weaknesses:

  • Dependence on a few major clients
  • Limited geographic presence
  • Challenges in adapting to rapidly evolving healthcare regulations
  • Potential cybersecurity vulnerabilities
  • High employee turnover rate

Opportunities

MEDNAX Inc can leverage the following opportunities to expand and grow:

  • Increasing demand for specialized medical services
  • Emerging markets and untapped geographical areas
  • Collaboration opportunities with other healthcare providers
  • Expansion into telemedicine and digital health solutions
  • Growth potential through strategic acquisitions and partnerships

Threats

MEDNAX Inc faces the following threats that may impact its business:

  • Intense competition in the healthcare industry
  • Economic fluctuations and healthcare budget cuts
  • Increasing regulatory scrutiny and compliance requirements
  • Rapid advancements in medical technology leading to potential obsolescence
  • Legal and malpractice risks

Pediatrix Medical Group Revenue by Segment

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Pediatrix Medical Group Revenue by Segment

Segmente20192018
Health Care, Patient Service3.09 B USD3.07 B USD
Hospitals Contracts396.81 M USD363.37 M USD
Management Service-215.97 M USD
Product and Service, Other24.74 M USD-
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Pediatrix Medical Group Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Pediatrix Medical Group historical P/E ratio, EBIT multiple, and P/S ratio

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Pediatrix Medical Group shares outstanding

The number of shares was Pediatrix Medical Group in 2024 — This indicates how many shares 83.33 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Pediatrix Medical Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Pediatrix Medical Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Pediatrix Medical Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Pediatrix Medical Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Pediatrix Medical Group stock splits

In Pediatrix Medical Group's history, there have been no stock splits.
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Pediatrix Medical Group.

Pediatrix Medical Group latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
3/31/20250.25 0.33  (32.74 %)2025 Q1
12/31/20240.38 0.51  (34.96 %)2024 Q4
9/30/20240.38 0.44  (15.91 %)2024 Q3
6/30/20240.32 0.34  (5.2 %)2024 Q2
3/31/20240.19 0.2  (4.28 %)2024 Q1
12/31/20230.33 0.32  (-4.42 %)2023 Q4
9/30/20230.45 0.32  (-28.22 %)2023 Q3
6/30/20230.41 0.39  (-5.82 %)2023 Q2
3/31/20230.24 0.23  (-2.38 %)2023 Q1
12/31/20220.5 0.47  (-5.68 %)2022 Q4
1
2
3
4
5
...
12

Eulerpool ESG Scorecard© for the Pediatrix Medical Group stock

Eulerpool World ESG Rating (EESG©)

70/ 100

🌱 Environment

50

👫 Social

79

🏛️ Governance

80

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees80
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Pediatrix Medical Group shareholders

%
Name
Stocks
Change
Date
15.05435 % BlackRock Institutional Trust Company, N.A.12,544,793-297,9363/31/2025
12.88053 % The Vanguard Group, Inc.10,733,3452,0403/31/2025
4.23147 % State Street Global Advisors (US)3,526,084-58,1473/31/2025
3.80480 % Dimensional Fund Advisors, L.P.3,170,537-88,0023/31/2025
3.76011 % Rubric Capital Management LP3,133,299-15,1413/31/2025
3.48528 % Fidelity Management & Research Company LLC2,904,284-5993/31/2025
2.41705 % Geode Capital Management, L.L.C.2,014,12866,3323/31/2025
2.37836 % Boston Partners1,981,88925,5363/31/2025
2.31402 % AllianceBernstein L.P.1,928,272-4,924,4195/31/2025
2.24670 % D. E. Shaw & Co., L.P.1,872,177-271,3193/31/2025
1
2
3
4
5
...
10

Pediatrix Medical Group Executives and Management Board

Dr. James Swift

(62)
Pediatrix Medical Group Director (since 2022)
Compensation 2.24 M

Mr. Curtis Pickert

(66)
Pediatrix Medical Group Executive Vice President, Chief Physician Executive
Compensation 1.88 M

Ms. Mary Ann Moore

(64)
Pediatrix Medical Group Executive Vice President, Chief Administrative Officer, General Counsel, Company Secretary
Compensation 1.83 M

Mr. Mark Ordan

(65)
Pediatrix Medical Group Executive Chairman of the Board, Chief Executive Officer (since 2020)
Compensation 554,454

Mr. Guy Sansone

(59)
Pediatrix Medical Group Lead Independent Director
Compensation 295,001
1
2
3

Pediatrix Medical Group Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
R1 RCM Stock
R1 RCM
SupplierCustomer0,660,650,890,31-0,460,48
OPKO Health Stock
OPKO Health
SupplierCustomer0,630,050,710,750,520,02
1

Most common questions regarding Pediatrix Medical Group

What values and corporate philosophy does Pediatrix Medical Group represent?

MEDNAX Inc is a leading provider of physician services, offering quality patient care across various specialties. The company values include excellence, integrity, and collaboration. MEDNAX strives to deliver outstanding healthcare services while upholding ethical standards. With a patient-centric approach, MEDNAX aims to consistently provide the highest level of medical expertise and compassionate care. The corporate philosophy of MEDNAX revolves around elevating patient outcomes through a multidisciplinary approach and fostering strong partnerships with healthcare professionals. MEDNAX Inc's commitment to excellence has earned them a trusted reputation in the healthcare industry.

In which countries and regions is Pediatrix Medical Group primarily present?

MEDNAX Inc primarily operates in the United States. As a leading provider of physician services, MEDNAX serves patients across various states including Alabama, Arizona, California, Florida, Georgia, Illinois, Maryland, Texas, and more. With a strong presence throughout the country, MEDNAX offers specialized healthcare solutions in various medical specialties, such as neonatology, anesthesia, maternal-fetal medicine, pediatric cardiology, and other pediatric subspecialties. With its extensive network of healthcare professionals and facilities, MEDNAX Inc continues to deliver quality medical services and contribute to the advancement of patient care in the United States.

What significant milestones has the company Pediatrix Medical Group achieved?

MEDNAX Inc, a leading provider of physician services, has achieved several significant milestones. Over the years, the company has expanded its geographic presence and enhanced its service offerings, solidifying its position in the healthcare industry. MEDNAX has successfully acquired and integrated several prominent physician practices, increasing its capacity to provide exceptional patient care. Additionally, the company has consistently demonstrated financial strength, recording steady revenue growth and delivering value to its shareholders. MEDNAX Inc has also received recognition for its commitment to quality, earning accreditations and accolades for its patient-centered approach. These accomplishments highlight MEDNAX Inc's dedication to delivering excellent healthcare services and driving innovation in the industry.

What is the history and background of the company Pediatrix Medical Group?

MEDNAX Inc, headquartered in Florida, is a leading medical services organization providing physician services across various healthcare specialties. Founded in 1979, MEDNAX has grown into a trusted provider of neonatal, pediatric cardiology, anesthesia, and other specialty services in the United States. With a focus on clinical quality and patient care, MEDNAX operates through its network of affiliated physician practices, serving hospitals and healthcare institutions nationwide. The company's commitment to delivering exceptional medical services has earned it a solid reputation in the industry. MEDNAX Inc continues to expand its presence and enhance its offerings, making it a reliable choice for quality healthcare services.

Who are the main competitors of Pediatrix Medical Group in the market?

The main competitors of MEDNAX Inc in the market are Envision Healthcare Corporation, Tenet Healthcare Corporation, and HCA Healthcare Inc.

In which industries is Pediatrix Medical Group primarily active?

MEDNAX Inc is primarily active in the healthcare industry.

What is the business model of Pediatrix Medical Group?

The business model of MEDNAX Inc revolves around providing physician services across various medical specialties. As a leading healthcare solutions provider, MEDNAX Inc partners with hospitals, clinics, and other healthcare facilities to enhance patient care through a network of highly skilled medical professionals. With a focus on pediatric and neonatal specialties, the company offers expert clinical services and management solutions, ensuring optimal healthcare outcomes. MEDNAX Inc's commitment to quality, innovation, and comprehensive care drives its success in delivering specialized medical services and contributing to the advancement of healthcare worldwide.

What is the P/E ratio of Pediatrix Medical Group 2025?

The P/E ratio cannot be calculated for Pediatrix Medical Group at the moment.

What is the P/S ratio of Pediatrix Medical Group 2025?

The P/S cannot be calculated for Pediatrix Medical Group currently.

What is the Quality Investing of Pediatrix Medical Group?

The Quality Investing for Pediatrix Medical Group is 1/10.

What is the revenue of Pediatrix Medical Group 2025?

The expected Pediatrix Medical Group revenue is 1.93 B USD.

How high is the profit of Pediatrix Medical Group 2025?

The expected Pediatrix Medical Group profit is 142.9 M USD.

What is the business model of Pediatrix Medical Group

MEDNAX Inc is a US-American company that operates in the field of medical services. The company offers medical solutions for various specialties, including anesthesia, neonatology, pediatrics, radiology, and pain therapy. MEDNAX is focused on providing high-quality medical care to patients in hospitals, doctor's offices, and clinics. MEDNAX offers a wide range of products and services to meet the needs of patients. The products offered include medical technology, hospital equipment, medical accessories and supplies, as well as special medications and injections. The company's services primarily include the employment of highly qualified medical professionals, such as anesthesiologists and pediatricians, who work in hospitals, practices, and clinics. MEDNAX pursues a multi-sector business model that aims to focus on specific medical specialties to enable better patient care. For this purpose, the company has established various business areas that offer specialized medical services and solutions. This includes in particular the areas of anesthesia, neonatology, and pediatrics. MEDNAX's anesthesia division offers anesthesiology solutions for hospitals, surgical facilities, and other medical institutions. This includes in particular the administration of anesthesia and pain therapy, monitoring of patients, and care of postoperative patients. The neonatology division specializes in the care of newborns who require intensive medical care. MEDNAX offers a wide range of products and services for this purpose, including ventilation, nutritional therapy, and monitoring systems. The pediatrics division of MEDNAX includes the care of children and adolescents in hospitals, clinics, and practices. MEDNAX's pediatricians specialize in the recognition and treatment of diseases that occur in childhood. MEDNAX is a company committed to improving the medical care of patients in the United States. With its wide range of products and services, as well as its expertise in various medical specialties, MEDNAX provides high-quality medical care. The company is dedicated to close collaboration with hospitals, clinics, and doctor's offices to ensure comprehensive treatment and care for patients.

What is the Pediatrix Medical Group dividend?

Pediatrix Medical Group pays a dividend of 0 USD distributed over payouts per year.

How often does Pediatrix Medical Group pay dividends?

The dividend cannot currently be calculated for Pediatrix Medical Group or the company does not pay out a dividend.

What is the Pediatrix Medical Group ISIN?

The ISIN of Pediatrix Medical Group is US58502B1061.

What is the Pediatrix Medical Group WKN?

The WKN of Pediatrix Medical Group is A0RELL.

What is the Pediatrix Medical Group ticker?

The ticker of Pediatrix Medical Group is MD.

How much dividend does Pediatrix Medical Group pay?

Over the past 12 months, Pediatrix Medical Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Pediatrix Medical Group is expected to pay a dividend of 0 USD.

What is the dividend yield of Pediatrix Medical Group?

The current dividend yield of Pediatrix Medical Group is .

When does Pediatrix Medical Group pay dividends?

Pediatrix Medical Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Pediatrix Medical Group?

Pediatrix Medical Group paid dividends every year for the past 0 years.

What is the dividend of Pediatrix Medical Group?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Pediatrix Medical Group located?

Pediatrix Medical Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Pediatrix Medical Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Pediatrix Medical Group from 7/30/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/30/2025.

When did Pediatrix Medical Group pay the last dividend?

The last dividend was paid out on 7/30/2025.

What was the dividend of Pediatrix Medical Group in the year 2024?

In the year 2024, Pediatrix Medical Group distributed 0 USD as dividends.

In which currency does Pediatrix Medical Group pay out the dividend?

The dividends of Pediatrix Medical Group are distributed in USD.

All fundamentals about Pediatrix Medical Group

Our stock analysis for Pediatrix Medical Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pediatrix Medical Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.